Intellijoint Surgical INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$330Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
211clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $49K
2020 $31K
2021 $57K
2022 $57K
2023 $69K
2024 $32K
2025 $34K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Orthopaedic Surgery $244K
Adult Reconstructive Orthopaedic Surgery $61K
Orthopaedic Surgery of The Spine $2,087
Sports Medicine (Orthopaedic Surgery) $488
Surgical Oncology $206
Hand Surgery $204

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Michael Bradley Wakefield, RI Orthopaedic Surgery $59,104.25
Matthew Barber Mobile, AL Orthopaedic Surgery $51,650.00
Russell Bodner Sycamore, IL Orthopaedic Surgery $40,483.06
Peter Sculco New York, NY Adult Reconstructive Orthopaedic Surgery $26,517.32
Brian Culp Princeton, NJ Orthopaedic Surgery $21,567.32
Ran Schwarzkopf Orange, CA $21,507.01
Nathanael Heckmann Los Angeles, CA Adult Reconstructive Orthopaedic Surgery $13,585.47
Stefan Kreuzer Houston, TX Orthopaedic Surgery $10,305.22
Jason Brannen The Woodlands, TX Orthopaedic Surgery $7,937.42
Morteza Meftah Bronx, NY Orthopaedic Surgery $7,450.38

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.